Report cover image

Polycystic Ovary Syndrome Supplements Market Size, Share & Trends Analysis Report By Ingredient (Myo?inositol-based supplements, Micronutrient & Omega-3), By Dosage Form (Capsules & tablets, Powders), By Indication, By Sales Channel, By Region, And Segmen

Publisher Grand View Research
Published Sep 26, 2025
Length 100 Pages
SKU # GV20471163

Description

Polycystic Ovary Syndrome Supplements Market Summary

The global polycystic ovary syndrome supplements market size was valued at USD 1.20 billion in 2024 and is projected to reach USD 3.80 billion by 2033, growing at a CAGR of 14.29% from 2025 to 2033. The industry is gaining momentum due to the rising prevalence of polycystic ovary syndrome (PCOS) worldwide and growing awareness of its long-term health implications.

PCOS affects women of reproductive age, and with improving diagnostic capabilities and education campaigns, more women are being diagnosed earlier. This expanding patient pool is fueling demand for solutions that can help manage symptoms naturally, creating a strong growth base for supplement manufacturers.

Global Polycystic Ovary Syndrome Supplements Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global polycystic ovary syndrome (PCOS) supplements market report on the basis of ingredient, dosage form, indication, sales channel, and region.
  • Ingredient Outlook (Revenue, USD Million, 2021 - 2033)
  • Myo inositol-based supplements
  • Micronutrient & Omega-3
  • Herbal Supplements
  • Others
  • Dosage Form Outlook (Revenue, USD Million, 2021 - 2033)
  • Capsules & tablets
  • Powders
  • Gummies
  • Liquids
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Menstrual Cycle Support
  • Hormonal Regulation
  • Fertility Improvement
  • Acne and Skin Health
  • Others
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hypermarket & Supermarket
  • Pharmacy & Drug stores
  • Online Stores
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

100 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Ingredient Segment
1.2.2. Dosage Form Segment
1.2.3. Indication Segment
1.2.4. Sales Channel Segment
1.3. Information Analysis
1.3.1. Market formulation & data visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Polycystic Ovary Syndrome Supplements Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising global prevalence of PCOS
3.2.1.2. Expansion of E-Commerce and DTC supplement brands
3.2.2. Market restraint analysis
3.2.2.1. Lack of stringent regulation
3.2.2.2. Low awareness in emerging markets
3.3. Polycystic Ovary Syndrome Supplements Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Polycystic Ovary Syndrome Supplements Market: Ingredients Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Polycystic Ovary Syndrome Supplements Market Ingredients Movement Analysis
4.3. Global Polycystic Ovary Syndrome Supplements Market Size & Trend Analysis, by Ingredients, 2021 to 2033 (USD Million)
4.4. Myo‑inositol-based Supplements
4.4.1. Myo‑inositol-based supplements market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Micronutrient & Omega-3
4.5.1. Micronutrient & omega-3 market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Herbal Supplements
4.6.1. Herbal supplements market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Polycystic Ovary Syndrome Supplements Market: Dosage Form Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Polycystic Ovary Syndrome Supplements Market Dosage Form Movement Analysis
5.3. Global Polycystic Ovary Syndrome Supplements Market Size & Trend Analysis, by Dosage Form, 2021 to 2033 (USD Million)
5.4. Capsules & Tablets
5.4.1. Capsules & tablets market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Powders
5.5.1. Powders market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Gummies
5.6.1. Gummies market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Liquids
5.7.1. Liquids market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Polycystic Ovary Syndrome Supplements Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Polycystic Ovary Syndrome Supplements Market Indication Movement Analysis
6.3. Global Polycystic Ovary Syndrome Supplements Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
6.4. Menstrual Cycle Support
6.4.1. Menstrual cycle support market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Hormonal Regulation
6.5.1. Hormonal regulation market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Fertility Improvement
6.6.1. Fertility improvement market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Acne and Skin Health
6.7.1. Acne and skin health market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Others
6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Polycystic Ovary Syndrome Supplements Market: Sales Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Polycystic Ovary Syndrome Supplements Market Sales Channel Movement Analysis
7.3. Global Polycystic Ovary Syndrome Supplements Market Size & Trend Analysis, by Sales Channel, 2021 to 2033 (USD Million)
7.4. Hypermarket & Supermarket
7.4.1. Hypermarket & supermarket market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Pharmacy & Drug stores
7.5.1. Pharmacy & drug stores market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Online Stores
7.6.1. Online stores market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Polycystic Ovary Syndrome Supplements Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Competitive scenario
8.4.1.3. Regulatory Framework
8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. Regulatory Framework
8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory Framework
8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory Framework
8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory Framework
8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory Framework
8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory Framework
8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory Framework
8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory Framework
8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory Framework
8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Regulatory Framework
8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Himalaya Wellness
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product/Service benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Theralogix
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product/Service benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Allara Health
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product/Service benchmarking
9.4.3.4. Strategic initiatives
9.4.4. The S’moo Co.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product/Service benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Fertility Family
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product/Service benchmarking
9.4.5.4. Strategic initiatives
9.4.6. SOVA
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product/Service benchmarking
9.4.6.4. Strategic initiatives
9.4.7. MyOva
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product/Service benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Black Girl Vitamins
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product/Service benchmarking
9.4.8.4. Strategic initiatives
9.4.9. New Leaf Products
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product/Service benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Zazzee Naturals
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product/Service benchmarking
9.4.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us